Education
About Us
Working with TipRanks
Follow Us
Boston Scientific (BSX)
NYSE:BSX
BSX Stock Chart & Stats
$100.96
$4.44(4.82%)
At close: 4:00 PM EST
$100.96
$4.44(4.82%)
Day’s Range― - ―
52-Week Range$85.98 - $109.50
Previous CloseN/A
Volume5.49M
Average Volume (3M)8.85M
Market Cap
$149.67B
Enterprise Value$156.91B
Total Cash (Recent Filing)$534.00M
Total Debt (Recent Filing)$12.03B
Price to Earnings (P/E)54.0
Beta0.81
Next Earnings
Feb 04, 2026EPS Estimate
0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding1,482,442,000
10 Day Avg. Volume10,625,694
30 Day Avg. Volume8,849,839
Financial Highlights & Ratios
PEG Ratio4.27
Price to Book (P/B)6.04
Price to Sales (P/S)7.85
P/FCF Ratio49.69
Enterprise Value/Market Cap1.05
Enterprise Value/Revenue8.48
Enterprise Value/Gross Profit13.42
Enterprise Value/Ebitda33.29
Forecast
1Y Price Target
$126.76Price Target Upside25.55% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering24
EPS Forecast (FY)3.04
Revenue Forecast (FY)$20.07B
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyBSX announced the acquisition of Nalu Medical, a private medtech company treating patients with chronic pain of peripheral nerve origin through peripheral nerve stimulation.
Financial PerformanceManagement raised guidance, now projecting FY25 growth of ~20%, and raised adj. EPS guidance as well.
Innovation In Medical DevicesOne of the most underappreciated aspects of Boston Scientific’s pipeline is its investment in a company with a first-in-class device to treat Type 2 Diabetes, which could have blockbuster potential.
Bears Say
Clinical Trial OutcomesOCEAN trial was stopped early due to a high likelihood of no difference in outcomes between its two arms.
Boston Scientific News
BSX FAQ
What was Boston Scientific’s price range in the past 12 months?
Boston Scientific lowest stock price was $85.98 and its highest was $109.50 in the past 12 months.
What is Boston Scientific’s market cap?
Boston Scientific’s market cap is $149.67B.
When is Boston Scientific’s upcoming earnings report date?
Boston Scientific’s upcoming earnings report date is Feb 04, 2026 which is in 67 days.
How were Boston Scientific’s earnings last quarter?
Boston Scientific released its earnings results on Oct 22, 2025. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.714 by $0.036.
Is Boston Scientific overvalued?
According to Wall Street analysts Boston Scientific’s price is currently Undervalued.
Does Boston Scientific pay dividends?
Boston Scientific does not currently pay dividends.
What is Boston Scientific’s EPS estimate?
Boston Scientific’s EPS estimate is 0.78.
How many shares outstanding does Boston Scientific have?
Boston Scientific has 1,482,442,000 shares outstanding.
What happened to Boston Scientific’s price movement after its last earnings report?
Boston Scientific reported an EPS of $0.75 in its last earnings report, beating expectations of $0.714. Following the earnings report the stock price went up 3.954%.
Which hedge fund is a major shareholder of Boston Scientific?
Currently, no hedge funds are holding shares in BSX
Boston Scientific Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$126.76 (25.55% Upside)
$126.76 (25.55% Upside)
Blogger Sentiment
Bullish
BSX Sentiment 81%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 3.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 7.2%
Last 30 Days ▲ 7.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.91%
12-Months-Change
Fundamentals
Return on Equity
12.66%
Trailing 12-Months
Asset Growth
12.16%
Trailing 12-Months
Company Description
Boston Scientific
Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a wide range of medical devices. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company operates in various sectors including cardiovascular, rhythm management, endoscopy, urology, and neuromodulation. Boston Scientific's core products include stents, catheters, pacemakers, and other innovative devices designed to improve patient outcomes and enhance the quality of life.
BSX Company Deck
BSX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong positive outlook with significant sales and EPS growth, driven by the success of key products like WATCHMAN and EP. However, there were challenges in the EMEA region and some product lines, particularly due to operational disruptions and market-specific headwinds.View all BSX earnings summariesBSX Revenue Breakdown
64.22% Cardiovascular
35.79% MedSurg
BSX Stock 12 Month Forecast
Average Price Target
$126.76
▲(25.55% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
28.34% Mutual Funds
11.24% Other Institutional Investors
38.88% Public Companies and Individual Investors